Targeting T cells against brain tumors with a bispecific ligand-antibody conjugate

International Journal of Cancer

Volumn 76, Issue 5, 1998, Pages 761-766

  Roy, Edward J ^a   Cho, Bryan K ^a   Rund, Laurie A ^a   Patrick, Todd A ^a   Kranz, David M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; BISPECIFIC ANTIBODY; LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CANCER SURVIVAL; CHOROID PLEXUS TUMOR; CONTROLLED STUDY; CYTOLYSIS; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; RECEPTOR AFFINITY; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIBODIES, NEOPLASM; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CARRIER PROTEINS; CHOROID PLEXUS NEOPLASMS; FEMALE; FLOW CYTOMETRY; FOLIC ACID; IMMUNOCONJUGATES; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES;

EID: 0031780611     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980529)76:5<761::AID-IJC23>3.0.CO;2-5     Document Type: Article

References (24)

1. BERGSAGEL, D.J., FINEGOLD, M.J., BUTEL, J.S., KUPSKY, W.J, and GARCEA, R.L., DNA sequences similar to those of simian virus-40 in ependymomas and choroid plexus tumors of childhood. N. Engl. J. Med., 326, 988-993 (1992).
2. CANEVARI, S. and 17 OTHERS, Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody. J. nat. Cancer Inst., 87, 1463-1469 (1995).
3. CHEN, J., ZHOU, J.H., MOKOTOFF, M., FANGER, M.W. and BALL, E.D., Lysis of small cell carcinoma of the lung (SCCL) cells by cytokine-activated monoeytes and natural killer cells in the presence of bispecific immuoconjugates containing a gastrin-releasing peptide (GRP) analog or a GRP antagonist. J. Hematother, 4, 369-376 (1995).
4. CHO, B.K., ROY, E.J., PATRICK, T.A, and KRANZ, D.M., Efficient CTL lysis of folate-receptor-positive tumor cells mediated by single-chain Fv/folate conjugates. Bioconj. Chem., 8, 338-346 (1997).
5. CHO, B.K., SCHODIN, B.A. and KRANZ, D.M., Characterization of a single-chain antibody to the β-chain of the T cell receptor. J. biol. Chem., 270, 25819-25826 (1995).
6. CONEY, L.R., TOMASSETTI, A., CARAYANNOPOULOS, L., FRASCA, V., KAMEN, B.A., COLNAGHI, M.I. and ZURAWSKI, V.R., JR., Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res., 51, 6125-6132 (1991).
7. FABRY, Z., TOPHAM, D.J., FEE, D., HERLEIN, J., CARLINO, J.A., HART, M.N. and SRIRAM, S., TGF-beta 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J. Immunol., 155, 325-332 (1995).
8. JUNG, G., FREIMANN T., VON MARSCHALL, Z., REISFELD, R.A. and WILMANNS, W., Target cell-induced T cell activation with bi- and trispecific antibody fragments. Europ. J. Immunol., 21, 2431-2435 (1991).
9. KRANZ, D.M., PATRICK, T.A., BRIGLE, K.E., SPINELLA, M.J. and ROY, E.J., Conjugates of folate and anti-T cell receptor antibodies specifically target folate-receptor-positive tumor cells for lysis. Proc. natl. Acad. Sci. (Wash.), 92, 9057-9061 (1995).
10. KROESEN, B.J., HELFRICH, W., BAKKER, A., WUBBENA, A.S., BAKKER, H., KAL, H.B., THE, T.H. and DE LEIJ, L., Reduction of EGP-2-positive pulmonary metastases by bispecific-antibody-redirected T cells in an immunocompetent rat model. Int. J. Cancer, 61, 812-818 (1995).
11. MANTOVANI, L.T., MIOTTI, S., MENARD, S., CANEVARI, S., RASPAGLIESI, F., BOTTINI, C., BOTTERO, F. and COLNAGHI, M.I., Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19. Europ. J. Cancer, 30A, 363-369 (1994).
12. MATHIAS, C.J., WANG, S., LEE, R.J., WATERS, D.J., LOW, P.S. and GREEN, M.A., Tumor-selective radiopharmaceutical targeting via receptor-mediate endocytosis of gallium-67-deferoxamine-folate. J. nucl. Med. 37, 1003-1008 (1996).
13. 2 antibodx prolong host survival in a murine xenograft model. Cancer Res., 51, 5716-5721 (1991).
14. MYLIN, L.M., DECKHUT, A.M., BONNEAU, R.H., KIERSTEAD, T.D., TEVETHIA, M.J., SIMMONS, D.T. and TEVETHIA, S.S., Cytotoxic T lymphocyte escape variants, induced mutations, and synthetic peptides define a dominant H-2Kb-restricted determinant in simian virus 40 tumor antigen. Virology, 208, 159-172 (1995).
15. NEWELL, K.A., ELLENHORN, J.D., BRUCE, D.S. and BLUESTONE, J.A., In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor. Proc. nat. Acad. Sci. (Wash.), 88, 1074-1078 (1991).
16. PATRICK, T.A., KRANZ, D.M., VAN DYKE., T.A. and ROY, E.J., Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice. J. Neuro-Oncol., 32, 111-123 (1997).
17. PENNA, C., DEAN, P.A. and NELSON, H., Antitumor X anti-CD3 bifunctional antibodies redirect T-cells activated in vivo with staphylococcal enterotoxin B to neutralize pulmonary metastases. Cancer Res., 54, 2738-2743 (1994).
18. + T cells. Cell Immunol., 158, 83-95 (1994).
19. 2 bispecitic antibodies. Int. J. Cancer. 67, 232-237 (1996).
20. VAN DYKE, T., FINLAY, C., and LEVINE, A.J., A comparison of several lines of transonic mice containing the SV early genes. Cold Spring Harbor Symp. Quant. Biol., 50, 671-678 (1985).
21. VAN DYKE, T.A., FINLAY, C., MILLER, D., MARKS, J., LOZANO, G. and LEVINE, A.J., Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice. J. Virol., 61, 2029-2032 (1987).
22. WEITMAN, S.D., LARK, R.H., CONEY, L.R., FORT, D.W., FRASCA, V., ZURAWSKI, V.R., JR. and KAMEN, B.A., Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res., 52, 3396-3401 (1992).
23. WESTERHOF, G.R., JANSEN, G., VAN EMMERIK, N., KATHMANN, I., RIJKSEN, G., JACKMAN, A.L. and SCHORNAGEL, J.H., Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems. Cancer Res., 51, 5507-5513 (1991).
24. YOKOTA, T., MILENIC, D.E., WHITLOW, M. and SCHLOM, J., Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res., 52, 3402-3408 (1992).